Search

everythinglearnresearchcommunity

for

Search:↓

Iron deficiency common in women, not always linked to hair loss; more research needed.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Doctors need to be better prepared to assess and treat obesity in patients.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

SHBG may be a useful early indicator and treatment target for PCOS.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Spironolactone helps regrow hair in women with hair loss.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.